Charles river launches viral vector tech transfer program to safeguard gene therapy development

Wilmington, mass.--(business wire)--charles river laboratories international, inc. (nyse: crl) today announced the introduction of its modular and fast track viral vector technology (tech) transfer frameworks. based on decades of viral vector contract development and manufacturing organization (cdmo) experience, the company has designed a methodical program to drive successful, accelerated process transfer to its maryland-based viral vector center of excellence (coe) in as little as nine months.
CRL Ratings Summary
CRL Quant Ranking